Early research (Phase 1)Study completedNCT04366622
What this trial is testing
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight
Who this might be right for
Clinical Pharmacology
Bayer 32